Evaluation of optimal psoriasis assessment tool (OPAT) incorporating both clinical and patient-reported outcomes for treatment of moderate-to-severe plaque psoriasis

被引：0
|
作者：
Leonardi, C. [2 ]
See, K. [1 ]
Burge, R. [1 ]
Gallo, G. [1 ]
McKean-Matthews, M. [3 ]
Goldblum, O. [1 ]
Wu, J. [4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Cent Dermatol, St Louis, MO USA
[3] Syneos Hlth, Raleigh, NC USA
[4] Dermatol Res & Educ Fdn, Irvine, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
541
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] The role of biologics in the treatment of moderate-to-severe plaque psoriasis
    Puig, Lluis
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (01): : 28 - 35
  • [22] Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
    Revicki, Dennis A.
    Willian, Mary Kaye
    Menter, Alan
    Gordon, Kenneth B.
    Kimball, Alexa B.
    Leonardi, Craig L.
    Langley, Richard G.
    Kimel, Miriam
    Okun, Martin
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (06) : 341 - 350
  • [23] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
    Armstrong, A. W.
    Griffiths, C.
    Tencer, T.
    Li, S.
    Zhang, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 67 - 67
  • [24] Effect of apremilast on patient-reported outcomes in patients with moderate to severe plaque psoriasis in the ESTEEM 1 trial
    Armstrong, April
    Griffiths, Christopher
    Tencer, Tom
    Li, Stan
    Zhang, Frank
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB231 - AB231
  • [25] Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
    Craig Leonardi
    Kyoungah See
    Gaia Gallo
    Missy McKean-Matthews
    Ying Zhang
    Orin Goldblum
    Lotus Mallbris
    Russel Burge
    Dermatology and Therapy, 2021, 11 : 1249 - 1263
  • [26] Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
    Leonardi, Craig
    See, Kyoungah
    Gallo, Gaia
    McKean-Matthews, Missy
    Zhang, Ying
    Goldblum, Orin
    Mallbris, Lotus
    Burge, Russel
    DERMATOLOGY AND THERAPY, 2021, 11 (04) : 1249 - 1263
  • [27] Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences
    Azhar, Aaminah
    Zaayman, Marcus
    Silfvast-Kaiser, Annika
    Kivelevitch, Dario
    Menter, Alan
    Paek, So Yeon
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [28] MEASUREMENT PROPERTIES OF THE PATIENT-REPORTED PSORIASIS SYMPTOM INVENTORY DAILY DIARY IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Viswanathan, H. N.
    Mutebi, A.
    Milmont, C. E.
    Gordon, K.
    Wilson, H.
    Zhang, H.
    Klekotka, P.
    Revicki, D. A.
    Augustin, M.
    Kricorian, G.
    Nirula, A.
    Strober, B.
    VALUE IN HEALTH, 2015, 18 (03) : A183 - A183
  • [29] Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
    Barker, Jonathan
    Baker, Hannah
    Nadeem, Ayeda
    Gu, Dong-Ha
    Girolomoni, Giampiero
    CLINICAL DRUG INVESTIGATION, 2021, 41 (11) : 1011 - 1020
  • [30] Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
    Jonathan Barker
    Hannah Baker
    Ayeda Nadeem
    Dong-Ha Gu
    Giampiero Girolomoni
    Clinical Drug Investigation, 2021, 41 : 1011 - 1020
12345